CR6122A - PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES - Google Patents

PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES

Info

Publication number
CR6122A
CR6122A CR6122A CR6122A CR6122A CR 6122 A CR6122 A CR 6122A CR 6122 A CR6122 A CR 6122A CR 6122 A CR6122 A CR 6122A CR 6122 A CR6122 A CR 6122A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutical composition
mucoses
water
soluble
mosm
Prior art date
Application number
CR6122A
Other languages
Spanish (es)
Inventor
Nishibe Yoshihisa
Kinoshita Wataru
Kawabe Hiroyuki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to CR6122A priority Critical patent/CR6122A/en
Publication of CR6122A publication Critical patent/CR6122A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invension provee una composicion farmaceutica para seraplicada a las mucosas, a ser utilizada en la terapia con drogas y que comprende una sustancia no soluble en agua y/o poco soluble en agua, un medicamento, y un medio acuoso, y que tiene una presion osmotica de menos 290 mOsm.The present invention provides a pharmaceutical composition to be applied to the mucous membranes, to be used in drug therapy and comprising a substance not soluble in water and / or poorly soluble in water, a medicament, and an aqueous medium, and having a osmotic pressure of minus 290 mOsm.

CR6122A 1999-10-19 1999-10-19 PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES CR6122A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR6122A CR6122A (en) 1999-10-19 1999-10-19 PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR6122A CR6122A (en) 1999-10-19 1999-10-19 PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES

Publications (1)

Publication Number Publication Date
CR6122A true CR6122A (en) 2009-10-16

Family

ID=41395353

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6122A CR6122A (en) 1999-10-19 1999-10-19 PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES

Country Status (1)

Country Link
CR (1) CR6122A (en)

Similar Documents

Publication Publication Date Title
GT199900180A (en) PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES.
AR029716A1 (en) DERMATOLOGICAL PRODUCTS IN SHEET FORM
AR025001A1 (en) FORMULATION OF COMMON SALT AND MOXIFLOXACINE
PT86536A (en) THERAPEUTIC SYSTEM FOR LOW SOLUTIVE ACTIVE INGREDIENTS
CO5150154A1 (en) SUBSTRATE COMPOSITION AND METHOD FOR USE FOR THE SEQUESTRAY OF SKIN IRRITANTS
IT1314185B1 (en) PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF SUBSTANCES ACTIVELY SOLUBLE IN AQUEOUS MEDIA
BR0014878A (en) Pharmaceutical composition containing cyclosonide for mucosal application
AR019690A1 (en) PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE SUBSTANCES
GT200300249A (en) DERMIC ADMINISTRATION OF A WATER SOLUBLE SELECTIVE CYCLOOXYGENASA-2 INHIBITOR
ES2092559T3 (en) PHARMACEUTICAL FORMULATION CONTAINING PENCICLOVIR.
MXPA01011842A (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF FLOROGLUCINOL AND PREPARATION OF THE SAME.
AR019245A1 (en) PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES
SV1999000181A (en) PHARMACEUTICAL COMPOSITION TO BE APPLIED TO THE MUCOUS REF. ER / CR-203.689
ES2032572T3 (en) A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION ON THE SKIN.
ES2178798T3 (en) NEFROPROTECTOR MEDICINAL.
HRP20070081T5 (en) NASAL PHARMACEUTICAL PREPARATION OF PIRIBEDIL
CR6300A (en) NEW ORAL FORMULATION
ES2139525B1 (en) USE OF DERIVATIVES OF THE WHEY AS CITOPROTECTORS AND SCARS.
ES2189639B1 (en) AQUOUS COMPOSITION CONTAINING ACETILSALICILIC ACID.
AR030964A1 (en) A PHARMACEUTICAL FORMULATION WITH A MATRIX THAT FORM A HYDROPHILIC GEL, FORMULATION THAT INCLUDES ONE OR MORE ACTIVE SUBSTANCES, AND METHOD TO PREPARE SUCH FORMULATION THAT HAS A SUBSTANTIELY INDEPENDENT PROLONGED RELEASE OF THE IONIC FORCE
ECSP993104A (en) NEW ORAL FORMULATION